EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 226 filers reported holding EDITAS MEDICINE INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $152,527 | +116332.8% | 18,533 | +2.1% | 0.00% | 0.0% |
| Q1 2023 | $131 | -13.8% | 18,154 | +5.8% | 0.00% | 0.0% |
| Q4 2022 | $152 | -99.9% | 17,154 | -9.3% | 0.00% | 0.0% |
| Q3 2022 | $231,000 | +3.6% | 18,919 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $223,000 | -29.4% | 18,879 | +13.5% | 0.00% | -50.0% |
| Q1 2022 | $316,000 | +634.9% | 16,636 | +918.7% | 0.00% | – |
| Q4 2021 | $43,000 | -86.7% | 1,633 | -79.3% | 0.00% | -100.0% |
| Q3 2021 | $323,000 | +127.5% | 7,893 | +214.0% | 0.00% | +100.0% |
| Q2 2021 | $142,000 | +65.1% | 2,514 | +22.7% | 0.00% | 0.0% |
| Q1 2021 | $86,000 | +19.4% | 2,049 | +98.7% | 0.00% | 0.0% |
| Q4 2020 | $72,000 | +380.0% | 1,031 | +82.8% | 0.00% | – |
| Q3 2020 | $15,000 | – | 564 | +7957.1% | 0.00% | – |
| Q4 2019 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |